Perrigo (NYSE:PRGO) Shares Up 7.6% – Here’s Why

Perrigo Company plc (NYSE:PRGO – Get Free Report) traded up 7.6% during trading on Wednesday. The company traded as high as $16.95 and last traded at $16.9550. 1,347,126 shares changed hands during mid-day trading, a decline of 55% from the average session volume of 2,987,811 shares. The stock had previously closed at $15.76.

Analyst Upgrades and Downgrades

PRGO has been the subject of several recent research reports. Wall Street Zen downgraded shares of Perrigo from a “buy” rating to a “hold” rating in a report on Saturday, October 31st. Zacks Research lowered shares of Perrigo from a “hold” rating to a “strong sell” rating in a research report on Thursday, October 29th. Weiss Ratings reiterated a “sell (d)” rating on shares of Perrigo in a research report on Tuesday, November 3rd. Finally, Canaccord Genuity Group raised their price objective on shares of Perrigo from $17.00 to $19.00 and gave the stock a “buy” rating in a research note on Friday, October 30th. One analyst has rated the stock with a Buy rating, three have given a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Reduce” and an average price target of $18.50.

Read Our Latest Report on PRGO

Perrigo Price Performance

The company has a debt-to-equity ratio of 1.35, a current ratio of 2.35 and a quick ratio of 1.36. The firm has a market capitalization of $2.21 billion, a PE ratio of -1.25, a P/E/G ratio of 1.82 and a beta of 0.71. The company has a 50-day moving average price of $15.32 and a 200-day moving average price of $12.59.

Perrigo (NYSE:PRGO – Get Free Report) last posted its quarterly earnings data on Wednesday, November 4th. The company reported $0.60 EPS for the quarter, topping analysts’ consensus estimates of $0.51 by $0.09. The firm had revenue of $988.60 million during the quarter, compared to analysts’ expectations of $984.80 million. Perrigo had a positive return on equity of 12.39% and a negative net margin of 43.27%. The firm’s quarterly revenue was down 5.2% compared to the same quarter last year. During the same quarter last year, the business posted $0.80 EPS. Sell-side analysts forecast that Perrigo Company plc will post 2.33 EPS for the current year.

Perrigo Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Friday, November 27th will be paid a dividend of $0.29 per share. The ex-dividend date of this dividend is Friday, November 27th. This represents a $1.16 annualized dividend and a dividend yield of 7.3%. Perrigo’s dividend payout ratio is presently -9.09%.

Institutional Trading of Perrigo

Hedge funds and other institutional investors have recently bought and sold shares of the company. Bank of America Corp DE raised its stake in Perrigo by 25.5% during the first quarter. Bank of America Corp DE now owns 1,568,598 shares of the company’s stock worth $16,847,000 after purchasing an additional 318,248 shares during the period. Gamco Investors INC. ET AL boosted its holdings in shares of Perrigo by 29.7% in the 1st quarter. Gamco Investors INC. ET AL now owns 1,397,866 shares of the company’s stock valued at $15,013,000 after purchasing an additional 320,081 shares during the last quarter. Diamond Hill Capital Management LLC Investment Advisor purchased a new stake in shares of Perrigo during the 2nd quarter valued at $4,066,000. Empowered Funds LLC grew its stake in shares of Perrigo by 41.6% during the 1st quarter. Empowered Funds LLC now owns 511,872 shares of the company’s stock valued at $5,498,000 after buying an additional 150,438 shares during the period. Finally, Gabelli Funds LLC raised its holdings in shares of Perrigo by 29.8% in the 1st quarter. Gabelli Funds LLC now owns 893,359 shares of the company’s stock worth $9,595,000 after purchasing an additional 205,311 shares during the period. 95.91% of the stock is owned by hedge funds and other institutional investors.

Perrigo Company Profile

(Get Free Report)

Perrigo is a global consumer healthcare company that develops, manufactures and markets over-the-counter medicines and other self-care products. Its offerings include treatments for allergies, coughs and colds, pain and digestive health, as well as skin care, oral care and infant nutrition products. The company supplies both its own consumer brands and store-brand products, which retailers sell under their own labels. Perrigo serves customers primarily in North America and Europe through retail and other healthcare channels.

See Also

Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.